Joyvié Health Raises $1.04M to Redesign Continence Underwear

Jan de Vries · 2026-06-05

UK-based Joyvié Health has closed its pre-Seed funding round, raising a total of $1.04 million for its continence underwear. The product is designed from first principles to significantly reduce stool-to-skin contact, maintain skin integrity, and ease the burden on caregivers. The funding comes from an Innovate UK grant, plus investments from HERmesa Angels, SyndicateRoom, Lavender Ventures, and individual angel investors. “Products designed for care should never cause harm. That’s not a vision statement. It’s the reason this company exists,” says Zoe Robson, Founder & CEO of Joyvié Health. ### A Personal Story That Sparked a Mission Joyvié Health was founded by Zoe Robson after her father, Fred, passed away in 2025. Fred was 77, fit, and sharp-minded when a late-stage pancreatic cancer diagnosis came on Christmas Eve 2024. Eleven weeks later, he was gone. During those weeks, Fred lost bowel control and had to wear a diaper. Feces trapped against skin breaks it down—moisture, pathogens, and pH imbalance cause damage that never fully heals. His skin broke down, and his dignity slipped away with each change. And Ruth, his wife and primary caregiver, carried a burden invisible to the outside world and impossibly hard to bear. “My parents didn’t deserve that,” says Zoe. “They were both at their most vulnerable—and the product meant to help them was making it worse. The skin breakdown, the shame, the loss of dignity, the weight on my mum. It wasn’t from lack of care. It’s a design failure.” ### The Problem with Current Solutions Faecal incontinence (FI) affects an estimated 656 million people worldwide. Yet the most common non-invasive solution—diapers and pads—hasn’t changed in decades. These products trap feces against the skin, leading to skin breakdown, infections, and loss of dignity. For caregivers, the process is time-consuming and emotionally draining. ### How Joyvié’s Design Changes Everything Joyvié’s underwear contains stool in a disposable pouch immediately after excretion. This design significantly reduces skin contact, preserves dignity, and cuts down on change time. Early testing shows about a 90% reduction in stool-to-skin contact and roughly 70% faster changes. That’s a game-changer for patients and caregivers alike. ### The Broader HealthTech Landscape in 2026 Joyvié’s pre-Seed round is part of a wave of HealthTech funding across the UK and Europe. Here’s a quick look at related deals: - Semble raised $37.5 million for its healthcare management platform. - Evaro secured $22.7 million to expand NHS-licensed health services. - JAAQ closed $16.2 million for enterprise partnerships. - Calibre emerged from stealth with $3 million for health “guesswork” solutions. - Nul raised $907,000 for alcohol-dependence care. - Recare in Berlin raised up to $40 million for its AI hospital platform. - Patronus raised $11.9 million for a senior-friendly emergency smartwatch. - Tucuvi raised $18.4 million for voice-AI nursing automation. - Ditto in Rotterdam raised $8.2 million to simplify medical information. - ShanX Medtech secured $26 million for antimicrobial-resistance diagnostics. - MedVasc raised $2.4 million for its anaesthesia catheter. Together, these rounds total over $187 million in related 2026 HealthTech funding. “At Lavender Ventures, we are committed to backing founders addressing large, underserved markets with innovative solutions that can meaningfully improve people’s lives,” says Gail Armstrong of Lavender Ventures. “We believe the market is ripe for innovation, and Joyvié’s approach has the potential to deliver significant benefits not only for individuals, but also for carers, healthcare systems, and the environment.” ### Why This Matters for US Professionals For US professionals in startup incorporation and EU Inc news, Joyvié’s story highlights a growing trend: HealthTech startups are increasingly addressing deeply personal, underserved needs with innovative designs. The funding landscape shows strong investor appetite for solutions that combine clinical efficacy with dignity and caregiver support. If you’re advising or investing in European HealthTech, keep an eye on companies like Joyvié that are rethinking basic products from first principles. The market is ready for change.